Hager Jeffrey 4
4 · IDEAYA Biosciences, Inc. · Filed Jul 26, 2019
Insider Transaction Report
Form 4
Hager Jeffrey
SVP, Chief Technology Officer
Transactions
- Exercise/Conversion
Common Stock
2019-06-19$4.31/sh+8,628$37,187→ 115,511 total - Exercise/Conversion
Common Stock
2019-07-10$4.31/sh+7,145$30,795→ 122,656 total - Exercise/Conversion
Stock Option (right to buy)
2019-06-19−8,628→ 40,420 totalExercise: $4.31Exp: 2028-02-26→ Common Stock (8,628 underlying) - Exercise/Conversion
Stock Option (right to buy)
2019-07-10−7,145→ 33,275 totalExercise: $4.31Exp: 2028-02-26→ Common Stock (7,145 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from February 27, 2018 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.